Search Results - "Minami, D"

Adsorption of Anionic and Cationic Surfactants on Anionic Colloids: Supercharging and Destabilization by Ahualli, S, Iglesias, G. R, Wachter, W, Dulle, M, Minami, D, Glatter, O

“…We present herein a study on the adsorption of anionic (SDS), cationic (CTAB), and nonionic (C12E5) surfactants onto anionic silica nanoparticles. The effects…”
Get full text

Immune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients by Kubo, T., Watanabe, H., Ninomiya, K., Kudo, K., Minami, D., Murakami, E., Ochi, N., Ninomiya, T., Harada, D., Yasugi, M., Ichihara, E., Ohashi, K., Fujiwara, K., Hotta, K., Tabata, M., Maeda, Y., Kiura, K.

Get full text

Enhanced CO2 adsorptivity of SWCNT by polycyclic aromatic hydrocarbon intercalation by Khoerunnisa, F., Minami, D., Fujimori, T., Hong, S. Y., Choi, Y. C., Sakamoto, H., Endo, M., Kaneko, K.

“…We tuned the electronic properties of single wall carbon nanotube (SWCNT) with intercalation of naphthalene derivatives (NDs) having different electron donor…”
Get full text

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY) by Hata, Tae, Ohashi, Kadoaki, Bessho, Akihiro, Hosokawa, Shinobu, Ishikawa, Nobuhisa, Yamasaki, Masahiro, Aoe, Keisuke, Kozuki, Toshiyuki, Harita, Shingo, Ueda, Yutaka, Murakami, Toshi, Fujimoto, Nobukazu, Yanai, Hiroyuki, Toyooka, Shinichi, Kiura, Katsuyuki, Gemba, K., Ikeda, G., Yasugi, M., Kurimoto, E., Nakano, K., Inoue, K., Miyoshi, S., Hamaguchi, N., Ito, R., Sano, Y., Takata, I., Mitani, A., Nishisaka, T., Nishida, A., Tamamoto, S., Fujitaka, K., Miyamoto, S., Hattori, N., Fujii, S., Sakugawa, M., Fukamatsu, N., Ogata, Y., Bandoh, S., Takigawa, N., Yamane, H., Honda, Y., Oka, M., Kittaka, M., Kubota, T., Yokoyama, A., Yokoyama, T., Sato, E., Shiota, Y., Kanematsu, T., Awaya, Y., Murakami, I., Kuyama, S., Kudo, K., Tamura, T., Umeno, T., Morichika, D., Sato, K., Harada, D., Nogami, N., Nishii, K., Fuchimoto, Y., Kawai, H., Watanabe, K., Tokumo, K., Isobe, T., Tsubata, Y., Inoue, M., Ichikawa, H., Nishioka, Y., Hanibuchi, M., Sumikawa, T., Kodani, M., Suyama, H., Makino, H., Shimizu, E., Obata, H., Ikegami, H., Chikamori, K., Maeda, T., Kamei, H., Ueoka, H., Kunihiro, Y., Kobayashi, T., Ueda, K., Hayashi, M., Murakami, J., Sato, A., Ichihara, E., Kubo, T., Ninomiya, T., Minami, D., Higo, H., Makimoto, G., Toyota, Y., Kayatani, H., Senoo, S., Kano, H., Watanabe, H., Itano, J., Tabata, M.

“…Human epidermal growth factor 2 (HER2) is a potential driver oncogene. Although HER2-targeted precision therapy has been tested in non-small cell lung cancer…”
Get full text

Updated analysis of a phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404 by Ninomiya, T., Nogami, N., Kozuki, T., Harada, D., Kubo, T., Ohashi, K., Kuyama, S., Kudo, K., Bessho, A., Fujimoto, N., Aoe, K., Shibayama, T., Minami, D., Sugimoto, K., Ochi, N., Takigawa, N., Hotta, K., Kiura, K.

Get full text

1525PUpdated analysis of a phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404 by Ninomiya, T, Nogami, N, Kozuki, T, Harada, D, Kubo, T, Ohashi, K, Kuyama, S, Kudo, K, Bessho, A, Fujimoto, N, Aoe, K, Shibayama, T, Minami, D, Sugimoto, K, Ochi, N, Takigawa, N, Hotta, K, Kiura, K

“…Abstract Background In a phase I study, Afa (30 mg/body daily) plus Bev (15 mg/kg every 3 weeks) was well tolerated and had evidence of favorable disease…”
Get full text

1525P - Updated analysis of a phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404 by Ninomiya, T., Nogami, N., Kozuki, T., Harada, D., Kubo, T., Ohashi, K., Kuyama, S., Kudo, K., Bessho, A., Fujimoto, N., Aoe, K., Shibayama, T., Minami, D., Sugimoto, K., Ochi, N., Takigawa, N., Hotta, K., Kiura, K.

“…In a phase I study, Afa (30mg/body daily) plus Bev (15mg/kg every 3 weeks) was well tolerated and had evidence of favorable disease control (Lung Cancer,…”
Get full text

A phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small-cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404 by Harada, D., Nogami, N., Kozuki, T., Ninomiya, T., Bessho, A., Kuyama, S., Fujimoto, N., Sugimoto, K., Aoe, K., Ochi, N., Minami, D., Fukamatsu, N., Kudo, K., Kiura, K.

Get full text

1473PImmune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients by Kubo, T, Watanabe, H, Ninomiya, K, Kudo, K, Minami, D, Murakami, E, Ochi, N, Ninomiya, T, Harada, D, Yasugi, M, Ichihara, E, Ohashi, K, Fujiwara, K, Hotta, K, Tabata, M, Maeda, Y, Kiura, K

Get full text

Impact of immune checkpoint inhibitors on subsequent chemotherapy by Watanabe, H., Kubo, T., Kudo, K., Minami, D., Murakami, T., Ochi, N., Ninomiya, T., Harada, D., Yasugi, M., Takeda, H., Ichihara, E., Ohashi, K., Hotta, K., Tabata, M., Maeda, Y., Kiura, K.

Get full text

D22 NOSOCOMIAL AND FUNGAL INFECTIONS: A Retrospective Analysis Of The Background Of Patients With Pulmonary Cryptococcosis And Diagnostic Methods Used by Morichika, D, Minami, D, Miyahara, N, Taniguchi, A, Kubo, T, Hotta, K, Kanehiro, A, Tanimoto, M, Kiura, K

Get full text

B39 INTERVENTIONAL PULMONARY MEDICINE: RECENT ADVANCES: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Of Hilar And Mediastinal Lymph Nodes Detected On 18f-Fluorodeoxyglucose Positron Emission Tomography/computed Tomography by Minami, D, Takigawa, N, Kato, Y, Ninomiya, T, Kubo, T, Ohashi, K, Hotta, K, Shibayama, T, Miyahara, N, Tabata, M, Kanehiro, A, Tanimoto, M, Kiura, K

Get full text

A43 EVOLVING TECHNOLOGIES IN CRITICAL CARE: Effectiveness Of Rapid On-Site Evaluation With Bioevaluator® During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration by Minami, D, Takigawa, N, Taniguchi, A, Waseda, K, Kubo, T, Ohashi, K, Sato, A, Hotta, K, Miyahara, N, Tabata, M, Kanehiro, A, Tanimoto, M, Kiura, K

Get full text

2PD Crizotinib could overcome acquired resistance to alectinib caused by HGF autocrine in ALK rearranged non-small cell lung cancer by Isozaki, H., Ichihara, E., Takigawa, N., Ohashi, K., Ochi, N., Yasugi, M., Ninomiya, T., Yamane, H., Minami, D., Kubo, T., Sato, A., Hotta, K., Sakai, K., Matsumoto, K., Hosokawa, S., Bessho, A., Sendo, T., Tanimoto, M., Kiura, K.

Get full text

152PEPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING CONFERRED ACQUIRED CRIZOTINIB RESISTANCE TO A NON-SMALL CELL LUNG CANCER CELL LINE HARBORING THE SLC34A2-ROS1 FUSION GENE by Kato, Y., Ohashi, K., Ichihara, E., Isozaki, H., Kudo, K., Minami, D., Kubo, T., Sato, A., Hotta, K., Tabata, M., Takigawa, N., Tanimoto, M., Kiura, K.

“…Abstract Aim: The ROS1 inhibitor crizotinib produces a remarkable response in patients with non-small cell lung cancer (NSCLC) harboring the ROS1 fusion gene…”
Get full text

Epidermal Growth Factor Receptor Signaling Conferred Acquired Crizotinib Resistance to a Non-Small Cell Lung Cancer Cell Line Harboring the Slc34A2-Ros1 Fusion Gene by Kato, Y., Ohashi, K., Ichihara, E., Isozaki, H., Kudo, K., Minami, D., Kubo, T., Sato, A., Hotta, K., Tabata, M., Takigawa, N., Tanimoto, M., Kiura, K.

Get full text

1584PACQUIRED RESISTANCE TO A NEW ALK INHIBITOR, ALECTINIB IN LUNG CANCER by Isozaki, H., Ichihara, E., Ohashi, K., Ochi, N., Yasugi, M., Kubo, T., Minami, D., Yamane, H., Sato, A.H., Kudo, K., Kato, Y., Hotta, K., Takigawa, N., Sendo, T., Tanimoto, M., Kiura, K.

“…Abstract Aim: Alectinib (CH/RO5424802) is a second generation anaplastic lymphoma kinase (ALK)-tyrosine kinase inhibitor (TKI). It has been reported to…”
Get full text

Acquired Resistance to a New Alk Inhibitor, Alectinib in Lung Cancer by Isozaki, H., Ichihara, E., Ohashi, K., Ochi, N., Yasugi, M., Kubo, T., Minami, D., Yamane, H., Sato, A.H., Kudo, K., Kato, Y., Hotta, K., Takigawa, N., Sendo, T., Tanimoto, M., Kiura, K.

Get full text

Usefulness of endobronchial ultrasound-guided transbronchial needle aspiration in distinguishing sarcoidosis from recurrent cancer in patients with lymphadenopathy after surgery by Minami, Daisuke, Takigawa, Nagio, Hayakawa, Hiromi, Mizuta, Makoto, Kudo, Kenichiro, Uchida, Kozi, Ichihara, Eiki, Sato, Akiko, Hotta, Katsuyuki, Tabata, Masahiro, Tanimoto, Mitsune, Kiura, Katsuyuki

“…Endobronchial ultrasound-guided transbronchial needle aspiration is a new minimally invasive test for investigating mediastinal and hilar lymphadenopathy. It…”
Get full text

Successful EUS-guided nondilated pancreatic duct stent placement in patient with refractory pancreatic fistula after pancreaticoduodenectomy by Minami, Kazuhiro, MD, Iwasaki, Eisuke, MD, PhD, Itoi, Takao, MD, PhD, Hibi, Taizo, MD, PhD, Kanai, Takanori, MD, PhD

Get full text